Adaptive Tissue Ablation Systems for Personalized Electroporation

Publication ID: 24-11857244_0005_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Adaptive Tissue Ablation Systems for Personalized Electroporation,” Published Technical Disclosure No. 24-11857244_0005_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857244_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,244.

Summary of the Inventive Concept

The present inventive concept discloses advanced tissue ablation systems that integrate real-time monitoring, adaptive frequency modulation, and personalized pulse sequences to achieve optimized electroporation outcomes.

Background and Problem Solved

The original patent disclosed methods and systems for tissue ablation using pulse shape designs, which have limitations in terms of fixed pulse sequences and lack of real-time monitoring. The present inventive concept addresses these limitations by introducing adaptive frequency modulation, 3D mapping, and real-time monitoring to ensure precise and personalized tissue ablation.

Detailed Description of the Inventive Concept

The new inventive concept comprises a system for tissue ablation that includes a pulse generator with adaptive frequency modulation, a 3D mapping module, and a sensor array for real-time monitoring of tissue impedance, temperature, and electrical conductivity. The system generates a customized pulse sequence based on the 3D map and adjusts it in real-time according to the detected changes in tissue properties. This allows for optimized electroporation outcomes, reduced treatment time, and minimized side effects.

Novelty and Inventive Step

The present inventive concept introduces a paradigm shift in tissue ablation by integrating real-time monitoring, adaptive frequency modulation, and personalized pulse sequences, which is a significant departure from the fixed pulse sequences of the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of machine learning algorithms to predict optimal pulse sequences, the integration of multiple sensing modalities, or the development of implantable devices for chronic tissue ablation.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the medical device industry, particularly in the fields of cancer treatment, cardiac ablation, and cosmetic dermatology. The market for tissue ablation devices is expected to grow significantly in the next decade, driven by the increasing demand for minimally invasive procedures and personalized medicine.

CPC Classifications

SectionClassGroup
A A61 A61B18/1206
A A61 A61B18/1402
A A61 A61N1/205
A A61 A61N1/327
A A61 A61B5/14539
A A61 A61B2018/00577
A A61 A61B2018/00613
A A61 A61B2018/00827
A A61 A61B2018/00994
A A61 A61B2018/1266
A A61 A61B2018/1472

Original Patent Information

Patent NumberUS 11,857,244
TitleMethods, systems, and apparatuses for tissue ablation using pulse shape designs
Assignee(s)RM2 TECHNOLOGY LLC, Inter Science GmbH